nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1B1—Dextrothyroxine—hypothyroidism	0.119	0.142	CbGbCtD
Lovastatin—SLCO1A2—Liothyronine—hypothyroidism	0.0956	0.114	CbGbCtD
Lovastatin—SLCO1A2—Levothyroxine—hypothyroidism	0.0956	0.114	CbGbCtD
Lovastatin—SLCO1A2—Liotrix—hypothyroidism	0.0933	0.111	CbGbCtD
Lovastatin—SLCO1B1—Levothyroxine—hypothyroidism	0.0902	0.107	CbGbCtD
Lovastatin—SLCO1B1—Liothyronine—hypothyroidism	0.0902	0.107	CbGbCtD
Lovastatin—SLCO1B1—Liotrix—hypothyroidism	0.0881	0.105	CbGbCtD
Lovastatin—CYP2C8—Levothyroxine—hypothyroidism	0.0382	0.0455	CbGbCtD
Lovastatin—CYP2C8—Liotrix—hypothyroidism	0.0373	0.0444	CbGbCtD
Lovastatin—ABCB1—Liothyronine—hypothyroidism	0.0258	0.0308	CbGbCtD
Lovastatin—ABCB1—Levothyroxine—hypothyroidism	0.0258	0.0308	CbGbCtD
Lovastatin—ABCB1—Liotrix—hypothyroidism	0.0252	0.03	CbGbCtD
Lovastatin—CYP3A4—Levothyroxine—hypothyroidism	0.0155	0.0184	CbGbCtD
Lovastatin—HDAC2—parathyroid gland—hypothyroidism	0.00621	0.0643	CbGeAlD
Lovastatin—UGT1A1—urine—hypothyroidism	0.00504	0.0522	CbGeAlD
Lovastatin—HDAC2—tongue—hypothyroidism	0.00327	0.0339	CbGeAlD
Lovastatin—ITGAL—heart—hypothyroidism	0.00311	0.0322	CbGeAlD
Lovastatin—ITGAL—cardiovascular system—hypothyroidism	0.00293	0.0304	CbGeAlD
Lovastatin—CYP2C19—urine—hypothyroidism	0.00273	0.0283	CbGeAlD
Lovastatin—PON3—pituitary gland—hypothyroidism	0.00255	0.0264	CbGeAlD
Lovastatin—ITGAL—adrenal gland—hypothyroidism	0.00232	0.024	CbGeAlD
Lovastatin—ITGAL—blood—hypothyroidism	0.00232	0.024	CbGeAlD
Lovastatin—ITGAL—thyroid gland—hypothyroidism	0.00224	0.0232	CbGeAlD
Lovastatin—PON3—thyroid gland—hypothyroidism	0.0022	0.0227	CbGeAlD
Lovastatin—ITGAL—female gonad—hypothyroidism	0.00216	0.0224	CbGeAlD
Lovastatin—Tenderness—Liotrix—hypothyroidism	0.00213	0.0342	CcSEcCtD
Lovastatin—PON3—female gonad—hypothyroidism	0.00212	0.022	CbGeAlD
Lovastatin—CYP2C9—urine—hypothyroidism	0.00212	0.0219	CbGeAlD
Lovastatin—ITGAL—testis—hypothyroidism	0.00192	0.0199	CbGeAlD
Lovastatin—PON3—testis—hypothyroidism	0.00188	0.0195	CbGeAlD
Lovastatin—ITGAL—liver—hypothyroidism	0.00181	0.0188	CbGeAlD
Lovastatin—PON3—liver—hypothyroidism	0.00178	0.0184	CbGeAlD
Lovastatin—ITGAL—cerebellum—hypothyroidism	0.00177	0.0184	CbGeAlD
Lovastatin—CYP3A4—urine—hypothyroidism	0.00161	0.0167	CbGeAlD
Lovastatin—CYP2D6—urine—hypothyroidism	0.00159	0.0165	CbGeAlD
Lovastatin—UGT1A3—liver—hypothyroidism	0.00154	0.016	CbGeAlD
Lovastatin—Body temperature increased—Liothyronine—hypothyroidism	0.00145	0.0233	CcSEcCtD
Lovastatin—HDAC2—heart—hypothyroidism	0.00124	0.0129	CbGeAlD
Lovastatin—Flushing—Levothyroxine—hypothyroidism	0.00118	0.0189	CcSEcCtD
Lovastatin—Flushing—Dextrothyroxine—hypothyroidism	0.00118	0.0189	CcSEcCtD
Lovastatin—HDAC2—cardiovascular system—hypothyroidism	0.00117	0.0121	CbGeAlD
Lovastatin—HMGCR—adrenal cortex—hypothyroidism	0.00116	0.012	CbGeAlD
Lovastatin—Alopecia—Dextrothyroxine—hypothyroidism	0.00112	0.018	CcSEcCtD
Lovastatin—Alopecia—Levothyroxine—hypothyroidism	0.00112	0.018	CcSEcCtD
Lovastatin—HMGCR—heart—hypothyroidism	0.00112	0.0116	CbGeAlD
Lovastatin—HDAC2—gonad—hypothyroidism	0.00106	0.011	CbGeAlD
Lovastatin—HMGCR—cardiovascular system—hypothyroidism	0.00106	0.011	CbGeAlD
Lovastatin—HDAC2—pituitary gland—hypothyroidism	0.00104	0.0108	CbGeAlD
Lovastatin—Tremor—Levothyroxine—hypothyroidism	0.00104	0.0166	CcSEcCtD
Lovastatin—Tremor—Dextrothyroxine—hypothyroidism	0.00104	0.0166	CcSEcCtD
Lovastatin—Angioedema—Dextrothyroxine—hypothyroidism	0.00101	0.0162	CcSEcCtD
Lovastatin—Angioedema—Levothyroxine—hypothyroidism	0.00101	0.0162	CcSEcCtD
Lovastatin—UGT1A1—blood—hypothyroidism	0.000963	0.00998	CbGeAlD
Lovastatin—HMGCR—gonad—hypothyroidism	0.00096	0.00994	CbGeAlD
Lovastatin—Arthralgia—Levothyroxine—hypothyroidism	0.000941	0.0151	CcSEcCtD
Lovastatin—Arthralgia—Dextrothyroxine—hypothyroidism	0.000941	0.0151	CcSEcCtD
Lovastatin—Anxiety—Levothyroxine—hypothyroidism	0.000938	0.015	CcSEcCtD
Lovastatin—Anxiety—Dextrothyroxine—hypothyroidism	0.000938	0.015	CcSEcCtD
Lovastatin—UGT2B7—testis—hypothyroidism	0.000937	0.0097	CbGeAlD
Lovastatin—HMGCR—pituitary gland—hypothyroidism	0.000937	0.0097	CbGeAlD
Lovastatin—HDAC2—adrenal gland—hypothyroidism	0.000928	0.0096	CbGeAlD
Lovastatin—HDAC2—blood—hypothyroidism	0.000927	0.0096	CbGeAlD
Lovastatin—CYP3A7—liver—hypothyroidism	0.000914	0.00947	CbGeAlD
Lovastatin—Confusional state—Levothyroxine—hypothyroidism	0.000909	0.0146	CcSEcCtD
Lovastatin—Confusional state—Dextrothyroxine—hypothyroidism	0.000909	0.0146	CcSEcCtD
Lovastatin—HDAC2—thyroid gland—hypothyroidism	0.000895	0.00927	CbGeAlD
Lovastatin—UGT2B7—liver—hypothyroidism	0.000886	0.00917	CbGeAlD
Lovastatin—Flushing—Liotrix—hypothyroidism	0.000867	0.0139	CcSEcCtD
Lovastatin—HDAC2—female gonad—hypothyroidism	0.000865	0.00896	CbGeAlD
Lovastatin—HMGCR—adrenal gland—hypothyroidism	0.000837	0.00867	CbGeAlD
Lovastatin—HMGCR—blood—hypothyroidism	0.000837	0.00866	CbGeAlD
Lovastatin—Alopecia—Liotrix—hypothyroidism	0.000825	0.0132	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000822	0.0132	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000822	0.0132	CcSEcCtD
Lovastatin—Insomnia—Dextrothyroxine—hypothyroidism	0.000816	0.0131	CcSEcCtD
Lovastatin—Insomnia—Levothyroxine—hypothyroidism	0.000816	0.0131	CcSEcCtD
Lovastatin—HMGCR—thyroid gland—hypothyroidism	0.000808	0.00836	CbGeAlD
Lovastatin—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000804	0.0129	CcSEcCtD
Lovastatin—Dyspnoea—Levothyroxine—hypothyroidism	0.000804	0.0129	CcSEcCtD
Lovastatin—SLCO1B1—blood—hypothyroidism	0.000802	0.0083	CbGeAlD
Lovastatin—Flatulence—Liotrix—hypothyroidism	0.000801	0.0128	CcSEcCtD
Lovastatin—Dysgeusia—Liotrix—hypothyroidism	0.000796	0.0128	CcSEcCtD
Lovastatin—HMGCR—female gonad—hypothyroidism	0.00078	0.00808	CbGeAlD
Lovastatin—Fatigue—Dextrothyroxine—hypothyroidism	0.000778	0.0125	CcSEcCtD
Lovastatin—Fatigue—Levothyroxine—hypothyroidism	0.000778	0.0125	CcSEcCtD
Lovastatin—CYP3A7-CYP3A51P—liver—hypothyroidism	0.000777	0.00805	CbGeAlD
Lovastatin—HDAC2—testis—hypothyroidism	0.000767	0.00794	CbGeAlD
Lovastatin—Vision blurred—Liotrix—hypothyroidism	0.000766	0.0123	CcSEcCtD
Lovastatin—Tremor—Liotrix—hypothyroidism	0.000762	0.0122	CcSEcCtD
Lovastatin—UGT1A1—liver—hypothyroidism	0.000753	0.0078	CbGeAlD
Lovastatin—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000743	0.0119	CcSEcCtD
Lovastatin—Feeling abnormal—Levothyroxine—hypothyroidism	0.000743	0.0119	CcSEcCtD
Lovastatin—Angioedema—Liotrix—hypothyroidism	0.000743	0.0119	CcSEcCtD
Lovastatin—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000737	0.0118	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000737	0.0118	CcSEcCtD
Lovastatin—HDAC2—liver—hypothyroidism	0.000725	0.00751	CbGeAlD
Lovastatin—Urticaria—Levothyroxine—hypothyroidism	0.000716	0.0115	CcSEcCtD
Lovastatin—Urticaria—Dextrothyroxine—hypothyroidism	0.000716	0.0115	CcSEcCtD
Lovastatin—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000713	0.0114	CcSEcCtD
Lovastatin—Abdominal pain—Levothyroxine—hypothyroidism	0.000713	0.0114	CcSEcCtD
Lovastatin—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000713	0.0114	CcSEcCtD
Lovastatin—Body temperature increased—Levothyroxine—hypothyroidism	0.000713	0.0114	CcSEcCtD
Lovastatin—HDAC2—cerebellum—hypothyroidism	0.000708	0.00734	CbGeAlD
Lovastatin—HMGCR—testis—hypothyroidism	0.000692	0.00717	CbGeAlD
Lovastatin—Arthralgia—Liotrix—hypothyroidism	0.000692	0.0111	CcSEcCtD
Lovastatin—Chest pain—Liotrix—hypothyroidism	0.000692	0.0111	CcSEcCtD
Lovastatin—Anxiety—Liotrix—hypothyroidism	0.00069	0.0111	CcSEcCtD
Lovastatin—Confusional state—Liotrix—hypothyroidism	0.000669	0.0107	CcSEcCtD
Lovastatin—Anaphylactic shock—Liotrix—hypothyroidism	0.000663	0.0106	CcSEcCtD
Lovastatin—Infection—Liotrix—hypothyroidism	0.000659	0.0106	CcSEcCtD
Lovastatin—HMGCR—liver—hypothyroidism	0.000654	0.00678	CbGeAlD
Lovastatin—Asthenia—Dextrothyroxine—hypothyroidism	0.000647	0.0104	CcSEcCtD
Lovastatin—Asthenia—Levothyroxine—hypothyroidism	0.000647	0.0104	CcSEcCtD
Lovastatin—HMGCR—cerebellum—hypothyroidism	0.000639	0.00662	CbGeAlD
Lovastatin—Pruritus—Dextrothyroxine—hypothyroidism	0.000638	0.0102	CcSEcCtD
Lovastatin—Pruritus—Levothyroxine—hypothyroidism	0.000638	0.0102	CcSEcCtD
Lovastatin—Anorexia—Liotrix—hypothyroidism	0.000632	0.0101	CcSEcCtD
Lovastatin—SLCO1B1—liver—hypothyroidism	0.000627	0.00649	CbGeAlD
Lovastatin—Diarrhoea—Levothyroxine—hypothyroidism	0.000617	0.00989	CcSEcCtD
Lovastatin—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000617	0.00989	CcSEcCtD
Lovastatin—ABCC2—adrenal gland—hypothyroidism	0.000608	0.00629	CbGeAlD
Lovastatin—ABCC2—blood—hypothyroidism	0.000608	0.00629	CbGeAlD
Lovastatin—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000604	0.00969	CcSEcCtD
Lovastatin—Insomnia—Liotrix—hypothyroidism	0.0006	0.00962	CcSEcCtD
Lovastatin—Paraesthesia—Liotrix—hypothyroidism	0.000596	0.00955	CcSEcCtD
Lovastatin—Dyspnoea—Liotrix—hypothyroidism	0.000591	0.00948	CcSEcCtD
Lovastatin—Decreased appetite—Liotrix—hypothyroidism	0.000577	0.00924	CcSEcCtD
Lovastatin—Vomiting—Dextrothyroxine—hypothyroidism	0.000573	0.00919	CcSEcCtD
Lovastatin—Vomiting—Levothyroxine—hypothyroidism	0.000573	0.00919	CcSEcCtD
Lovastatin—Fatigue—Liotrix—hypothyroidism	0.000572	0.00917	CcSEcCtD
Lovastatin—Rash—Dextrothyroxine—hypothyroidism	0.000569	0.00912	CcSEcCtD
Lovastatin—Rash—Levothyroxine—hypothyroidism	0.000569	0.00912	CcSEcCtD
Lovastatin—Dermatitis—Dextrothyroxine—hypothyroidism	0.000568	0.00911	CcSEcCtD
Lovastatin—Dermatitis—Levothyroxine—hypothyroidism	0.000568	0.00911	CcSEcCtD
Lovastatin—Constipation—Liotrix—hypothyroidism	0.000567	0.00909	CcSEcCtD
Lovastatin—Headache—Dextrothyroxine—hypothyroidism	0.000565	0.00906	CcSEcCtD
Lovastatin—Headache—Levothyroxine—hypothyroidism	0.000565	0.00906	CcSEcCtD
Lovastatin—Feeling abnormal—Liotrix—hypothyroidism	0.000547	0.00876	CcSEcCtD
Lovastatin—CYP2C9—heart—hypothyroidism	0.000543	0.00562	CbGeAlD
Lovastatin—Gastrointestinal pain—Liotrix—hypothyroidism	0.000542	0.0087	CcSEcCtD
Lovastatin—SLCO1A2—testis—hypothyroidism	0.00054	0.00559	CbGeAlD
Lovastatin—Nausea—Levothyroxine—hypothyroidism	0.000536	0.00859	CcSEcCtD
Lovastatin—Nausea—Dextrothyroxine—hypothyroidism	0.000536	0.00859	CcSEcCtD
Lovastatin—Urticaria—Liotrix—hypothyroidism	0.000527	0.00845	CcSEcCtD
Lovastatin—Body temperature increased—Liotrix—hypothyroidism	0.000524	0.00841	CcSEcCtD
Lovastatin—Abdominal pain—Liotrix—hypothyroidism	0.000524	0.00841	CcSEcCtD
Lovastatin—CYP2C19—blood—hypothyroidism	0.000522	0.00541	CbGeAlD
Lovastatin—CYP2C9—cardiovascular system—hypothyroidism	0.000512	0.0053	CbGeAlD
Lovastatin—CYP2C8—pituitary gland—hypothyroidism	0.00051	0.00528	CbGeAlD
Lovastatin—SLCO1A2—liver—hypothyroidism	0.00051	0.00528	CbGeAlD
Lovastatin—ABCC2—testis—hypothyroidism	0.000503	0.00521	CbGeAlD
Lovastatin—SLCO1A2—cerebellum—hypothyroidism	0.000498	0.00516	CbGeAlD
Lovastatin—Hypersensitivity—Liotrix—hypothyroidism	0.000489	0.00784	CcSEcCtD
Lovastatin—Asthenia—Liotrix—hypothyroidism	0.000476	0.00763	CcSEcCtD
Lovastatin—ABCC2—liver—hypothyroidism	0.000475	0.00492	CbGeAlD
Lovastatin—Pruritus—Liotrix—hypothyroidism	0.000469	0.00752	CcSEcCtD
Lovastatin—CYP2C8—blood—hypothyroidism	0.000456	0.00472	CbGeAlD
Lovastatin—Diarrhoea—Liotrix—hypothyroidism	0.000454	0.00728	CcSEcCtD
Lovastatin—Dizziness—Liotrix—hypothyroidism	0.000439	0.00703	CcSEcCtD
Lovastatin—Vomiting—Liotrix—hypothyroidism	0.000422	0.00676	CcSEcCtD
Lovastatin—Rash—Liotrix—hypothyroidism	0.000418	0.00671	CcSEcCtD
Lovastatin—Dermatitis—Liotrix—hypothyroidism	0.000418	0.0067	CcSEcCtD
Lovastatin—Headache—Liotrix—hypothyroidism	0.000416	0.00666	CcSEcCtD
Lovastatin—CYP3A5—blood—hypothyroidism	0.000411	0.00426	CbGeAlD
Lovastatin—CYP2C19—liver—hypothyroidism	0.000408	0.00423	CbGeAlD
Lovastatin—CYP2C9—blood—hypothyroidism	0.000405	0.00419	CbGeAlD
Lovastatin—Nausea—Liotrix—hypothyroidism	0.000394	0.00632	CcSEcCtD
Lovastatin—CYP3A5—female gonad—hypothyroidism	0.000384	0.00397	CbGeAlD
Lovastatin—CYP2C8—testis—hypothyroidism	0.000377	0.0039	CbGeAlD
Lovastatin—CYP2C8—liver—hypothyroidism	0.000356	0.00369	CbGeAlD
Lovastatin—CYP3A5—liver—hypothyroidism	0.000322	0.00333	CbGeAlD
Lovastatin—CYP2C9—liver—hypothyroidism	0.000317	0.00328	CbGeAlD
Lovastatin—CYP3A4—blood—hypothyroidism	0.000309	0.0032	CbGeAlD
Lovastatin—CYP2D6—blood—hypothyroidism	0.000304	0.00315	CbGeAlD
Lovastatin—ABCB1—adrenal cortex—hypothyroidism	0.000303	0.00314	CbGeAlD
Lovastatin—ABCB1—heart—hypothyroidism	0.000293	0.00303	CbGeAlD
Lovastatin—CYP2D6—female gonad—hypothyroidism	0.000283	0.00293	CbGeAlD
Lovastatin—ABCB1—cardiovascular system—hypothyroidism	0.000276	0.00286	CbGeAlD
Lovastatin—CYP2D6—testis—hypothyroidism	0.000251	0.0026	CbGeAlD
Lovastatin—ABCB1—gonad—hypothyroidism	0.000251	0.0026	CbGeAlD
Lovastatin—ABCB1—pituitary gland—hypothyroidism	0.000245	0.00253	CbGeAlD
Lovastatin—CYP3A4—liver—hypothyroidism	0.000241	0.0025	CbGeAlD
Lovastatin—CYP2D6—liver—hypothyroidism	0.000238	0.00246	CbGeAlD
Lovastatin—CYP2D6—cerebellum—hypothyroidism	0.000232	0.0024	CbGeAlD
Lovastatin—ABCB1—adrenal gland—hypothyroidism	0.000219	0.00226	CbGeAlD
Lovastatin—ABCB1—blood—hypothyroidism	0.000219	0.00226	CbGeAlD
Lovastatin—ABCB1—thyroid gland—hypothyroidism	0.000211	0.00218	CbGeAlD
Lovastatin—ABCB1—female gonad—hypothyroidism	0.000204	0.00211	CbGeAlD
Lovastatin—ABCB1—testis—hypothyroidism	0.000181	0.00187	CbGeAlD
Lovastatin—ABCB1—liver—hypothyroidism	0.000171	0.00177	CbGeAlD
Lovastatin—ABCB1—cerebellum—hypothyroidism	0.000167	0.00173	CbGeAlD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.000118	0.1	CbGpPWpGaD
Lovastatin—SLCO1A2—Transport of organic anions—AVP—hypothyroidism	5.59e-05	0.0473	CbGpPWpGaD
Lovastatin—SLCO1B1—Transport of organic anions—AVP—hypothyroidism	4.78e-05	0.0404	CbGpPWpGaD
Lovastatin—ITGAL—Integrin-mediated Cell Adhesion—VAV3—hypothyroidism	4.27e-05	0.0362	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	4.16e-05	0.0352	CbGpPWpGaD
Lovastatin—UGT1A3—NRF2 pathway—SLC5A7—hypothyroidism	3.03e-05	0.0256	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—SLC5A7—hypothyroidism	2.58e-05	0.0218	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	2.26e-05	0.0191	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CLTC—hypothyroidism	2.14e-05	0.0181	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—SLC5A7—hypothyroidism	2.09e-05	0.0177	CbGpPWpGaD
Lovastatin—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	2.07e-05	0.0175	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—SLC5A7—hypothyroidism	2.04e-05	0.0173	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—NKX2-1—hypothyroidism	1.91e-05	0.0161	CbGpPWpGaD
Lovastatin—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	1.77e-05	0.015	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—SH2B3—hypothyroidism	1.7e-05	0.0144	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	1.66e-05	0.0141	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—IGF1—hypothyroidism	1.57e-05	0.0133	CbGpPWpGaD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—VAV3—hypothyroidism	1.54e-05	0.013	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—SH2B3—hypothyroidism	1.5e-05	0.0127	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	1.41e-05	0.012	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CLTC—hypothyroidism	1.3e-05	0.011	CbGpPWpGaD
Lovastatin—UGT1A3—NRF2 pathway—SLC5A5—hypothyroidism	1.21e-05	0.0103	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	1.21e-05	0.0102	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	1.17e-05	0.00992	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—VAV3—hypothyroidism	1.17e-05	0.00989	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—ZNF764—hypothyroidism	1.09e-05	0.00924	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—SLC5A5—hypothyroidism	1.03e-05	0.00872	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	1e-05	0.00848	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	9.86e-06	0.00835	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—SLC5A5—hypothyroidism	8.37e-06	0.00708	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—SLC5A5—hypothyroidism	8.16e-06	0.00691	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—IYD—hypothyroidism	8.04e-06	0.00681	CbGpPWpGaD
Lovastatin—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.5e-06	0.00635	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—AVP—hypothyroidism	7.24e-06	0.00613	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—IGF1—hypothyroidism	7.19e-06	0.00609	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.18e-06	0.00608	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—THRA—hypothyroidism	7.03e-06	0.00595	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ATP5O—hypothyroidism	6.84e-06	0.00579	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—PRL—hypothyroidism	6.62e-06	0.00561	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—IYD—hypothyroidism	6.56e-06	0.00555	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.54e-06	0.00554	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TPO—hypothyroidism	6.43e-06	0.00544	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.14e-06	0.0052	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—VAV3—hypothyroidism	6.13e-06	0.00519	CbGpPWpGaD
Lovastatin—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.08e-06	0.00515	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.96e-06	0.00504	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.95e-06	0.00504	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—VAV3—hypothyroidism	5.67e-06	0.0048	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.65e-06	0.00478	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—IYD—hypothyroidism	5.57e-06	0.00472	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ATP5O—hypothyroidism	5.57e-06	0.00472	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—POMC—hypothyroidism	5.56e-06	0.0047	CbGpPWpGaD
Lovastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.42e-06	0.00459	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.42e-06	0.00459	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TPO—hypothyroidism	5.24e-06	0.00444	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SH2B3—hypothyroidism	5.23e-06	0.00443	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.09e-06	0.00431	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NKX2-5—hypothyroidism	5.01e-06	0.00424	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—IYD—hypothyroidism	4.85e-06	0.00411	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	4.83e-06	0.00409	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ATP5O—hypothyroidism	4.74e-06	0.00401	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—POMC—hypothyroidism	4.73e-06	0.004	CbGpPWpGaD
Lovastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.7e-06	0.00398	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—THRB—hypothyroidism	4.53e-06	0.00384	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—IYD—hypothyroidism	4.53e-06	0.00384	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TPO—hypothyroidism	4.46e-06	0.00377	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.45e-06	0.00377	CbGpPWpGaD
Lovastatin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.39e-06	0.00372	CbGpPWpGaD
Lovastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.19e-06	0.00355	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—IYD—hypothyroidism	4.15e-06	0.00351	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ATP5O—hypothyroidism	4.13e-06	0.00349	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TPO—hypothyroidism	3.88e-06	0.00329	CbGpPWpGaD
Lovastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.85e-06	0.00326	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ATP5O—hypothyroidism	3.85e-06	0.00326	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—POMC—hypothyroidism	3.84e-06	0.00325	CbGpPWpGaD
Lovastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.82e-06	0.00324	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—IYD—hypothyroidism	3.81e-06	0.00323	CbGpPWpGaD
Lovastatin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.81e-06	0.00322	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	3.8e-06	0.00322	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TPO—hypothyroidism	3.62e-06	0.00307	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.6e-06	0.00304	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VAV3—hypothyroidism	3.59e-06	0.00304	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ATP5O—hypothyroidism	3.53e-06	0.00299	CbGpPWpGaD
Lovastatin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.4e-06	0.00288	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TPO—hypothyroidism	3.32e-06	0.00281	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ATP5O—hypothyroidism	3.24e-06	0.00274	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—POMC—hypothyroidism	3.23e-06	0.00273	CbGpPWpGaD
Lovastatin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.12e-06	0.00265	CbGpPWpGaD
Lovastatin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.1e-06	0.00262	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	3.08e-06	0.0026	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.07e-06	0.0026	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TPO—hypothyroidism	3.05e-06	0.00258	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TSHB—hypothyroidism	2.98e-06	0.00252	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.87e-06	0.00243	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—IYD—hypothyroidism	2.75e-06	0.00233	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3C2A—hypothyroidism	2.65e-06	0.00225	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.62e-06	0.00222	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.61e-06	0.00221	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CLTC—hypothyroidism	2.58e-06	0.00219	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.55e-06	0.00216	CbGpPWpGaD
Lovastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.52e-06	0.00213	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.46e-06	0.00208	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TSHB—hypothyroidism	2.43e-06	0.00205	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—IYD—hypothyroidism	2.39e-06	0.00202	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ATP5O—hypothyroidism	2.34e-06	0.00198	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—POMC—hypothyroidism	2.33e-06	0.00198	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—AVP—hypothyroidism	2.26e-06	0.00191	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TRH—hypothyroidism	2.23e-06	0.00189	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SLC5A5—hypothyroidism	2.23e-06	0.00189	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IGF1—hypothyroidism	2.21e-06	0.00187	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TPO—hypothyroidism	2.2e-06	0.00186	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3C2A—hypothyroidism	2.16e-06	0.00183	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—IYD—hypothyroidism	2.13e-06	0.0018	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—IYD—hypothyroidism	2.08e-06	0.00176	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TSHB—hypothyroidism	2.06e-06	0.00175	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—AVP—hypothyroidism	2.06e-06	0.00174	CbGpPWpGaD
Lovastatin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.04e-06	0.00173	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ATP5O—hypothyroidism	2.03e-06	0.00172	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—POMC—hypothyroidism	2.02e-06	0.00171	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TSHR—hypothyroidism	1.99e-06	0.00168	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TSHB—hypothyroidism	1.99e-06	0.00168	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—IYD—hypothyroidism	1.96e-06	0.00166	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—IYD—hypothyroidism	1.94e-06	0.00164	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.93e-06	0.00164	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TPO—hypothyroidism	1.91e-06	0.00161	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PRL—hypothyroidism	1.88e-06	0.00159	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3C2A—hypothyroidism	1.84e-06	0.00156	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SLC5A5—hypothyroidism	1.82e-06	0.00154	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ATP5O—hypothyroidism	1.81e-06	0.00153	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—POMC—hypothyroidism	1.8e-06	0.00153	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TSHB—hypothyroidism	1.8e-06	0.00152	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SH2B3—hypothyroidism	1.77e-06	0.0015	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ATP5O—hypothyroidism	1.77e-06	0.0015	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.77e-06	0.0015	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TPO—hypothyroidism	1.7e-06	0.00144	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TSHB—hypothyroidism	1.68e-06	0.00142	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ATP5O—hypothyroidism	1.67e-06	0.00141	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TPO—hypothyroidism	1.66e-06	0.00141	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—POMC—hypothyroidism	1.66e-06	0.00141	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ATP5O—hypothyroidism	1.65e-06	0.0014	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—POMC—hypothyroidism	1.65e-06	0.00139	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3C2A—hypothyroidism	1.6e-06	0.00136	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.58e-06	0.00134	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.58e-06	0.00134	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TPO—hypothyroidism	1.57e-06	0.00133	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	1.56e-06	0.00132	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TPO—hypothyroidism	1.55e-06	0.00131	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SLC5A5—hypothyroidism	1.54e-06	0.00131	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TSHB—hypothyroidism	1.54e-06	0.0013	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3C2A—hypothyroidism	1.49e-06	0.00127	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.44e-06	0.00122	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TSHB—hypothyroidism	1.41e-06	0.00119	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	1.37e-06	0.00116	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.35e-06	0.00114	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SLC5A5—hypothyroidism	1.34e-06	0.00114	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PRL—hypothyroidism	1.32e-06	0.00111	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—IYD—hypothyroidism	1.28e-06	0.00108	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	1.26e-06	0.00106	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SLC5A5—hypothyroidism	1.26e-06	0.00106	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.23e-06	0.00104	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VAV3—hypothyroidism	1.22e-06	0.00103	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AVP—hypothyroidism	1.17e-06	0.000993	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—POMC—hypothyroidism	1.17e-06	0.000987	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.15e-06	0.000974	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.09e-06	0.000922	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.09e-06	0.000919	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SLC5A5—hypothyroidism	1.06e-06	0.000894	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TPO—hypothyroidism	1.02e-06	0.000867	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TSHB—hypothyroidism	1.02e-06	0.000863	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	9.68e-07	0.000819	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—POMC—hypothyroidism	9.5e-07	0.000805	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	9.08e-07	0.000769	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TSHB—hypothyroidism	8.83e-07	0.000747	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—POMC—hypothyroidism	8.08e-07	0.000684	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TSHB—hypothyroidism	7.88e-07	0.000667	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	7.87e-07	0.000666	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—POMC—hypothyroidism	7.79e-07	0.00066	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.76e-07	0.000657	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TSHB—hypothyroidism	7.69e-07	0.000651	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC5A5—hypothyroidism	7.63e-07	0.000646	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF1—hypothyroidism	7.5e-07	0.000635	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TSHB—hypothyroidism	7.25e-07	0.000614	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TSHB—hypothyroidism	7.19e-07	0.000608	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—POMC—hypothyroidism	7.04e-07	0.000596	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	7.02e-07	0.000595	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.93e-07	0.000587	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3C2A—hypothyroidism	6.86e-07	0.00058	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC5A5—hypothyroidism	6.61e-07	0.00056	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—POMC—hypothyroidism	6.57e-07	0.000556	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	6.46e-07	0.000547	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	6.4e-07	0.000542	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.32e-07	0.000535	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—POMC—hypothyroidism	6.02e-07	0.000509	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC5A5—hypothyroidism	5.9e-07	0.000499	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC5A5—hypothyroidism	5.76e-07	0.000487	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—POMC—hypothyroidism	5.52e-07	0.000468	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC5A5—hypothyroidism	5.43e-07	0.000459	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC5A5—hypothyroidism	5.38e-07	0.000455	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TSHB—hypothyroidism	4.74e-07	0.000401	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	4.22e-07	0.000358	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—POMC—hypothyroidism	3.99e-07	0.000338	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.55e-07	0.0003	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—POMC—hypothyroidism	3.46e-07	0.000293	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—POMC—hypothyroidism	3.09e-07	0.000261	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—POMC—hypothyroidism	3.01e-07	0.000255	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—POMC—hypothyroidism	2.84e-07	0.00024	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—POMC—hypothyroidism	2.81e-07	0.000238	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—POMC—hypothyroidism	1.86e-07	0.000157	CbGpPWpGaD
